TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment Options for Recurrent Pheochromocytoma
Source: Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: November 1, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Recurrent Pheochromocytoma
Treatment options for recurrent pheochromocytoma include:
Surgery.
Source links and citations
Palliative therapy.
Source links and citations
After resection of a localized pheochromocytoma presumed to represent a benign tumor and documented normal postoperative biochemical testing, disease recurrence occurs in 6.5% to 16.5% of patients, and 50% of patients with disease recurrence develop metastatic disease.[1-3] Insufficient data exist to determine recurrence rates after complete surgical resection of regional or metastatic disease.
Continue within this section
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice